| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |